Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective study. [electronic resource]
Producer: 20190813Description: 1754-1762 p. digitalISSN:- 1759-7714
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Biomarkers, Tumor
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Neoplasm Staging
- Proportional Hazards Models
- Protein Kinase Inhibitors -- administration & dosage
- Pyridines -- administration & dosage
- Retreatment
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.